MedPath

AMP WellBeing Intervention trial

Not Applicable
Completed
Conditions
Anxiety and/or depression
Mental and Behavioural Disorders
Anxiety disorder, unspecified
Registration Number
ISRCTN68572159
Lead Sponsor
niversity of Liverpool (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Male and female aged 50 and over for Croxteth and Wythenshawe participants
2. Aged 18 and over for Picton and Longsight participants
3. Somali heritage in Picton and South Asian (Pakistani or Bangladeshi) in Longsight; registered with one of the 16 primary care practices working with the AMP Development Partnership
4. Scoring 10 or more on the Patient Health Questionnaire 9 (PHQ)-9 and/or the Generalized Anxiety Disorder 7 (GAD-7)

Exclusion Criteria

1. Currently deemed to be at significant risk to themselves or others
2. Significant learning disabilities and cognitive impairment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CORE-OM, a 34-item self report scale designed to measure global distress, including subjective well being, life/social functioning and risk measured at baseline and 20 weeks
Secondary Outcome Measures
NameTimeMethod
1. PHQ-9 for depression<br>2. GAD-7 for anxiety<br>3. The Work and Social Adjustment Scale <br>4. The EQ-5D for quality of life<br>Measured at baseline and 20 weeks
© Copyright 2025. All Rights Reserved by MedPath